Cheetah Medical, Inc., a Newton Center, MA-based provider of non-invasive hemodynamic monitoring systems, secured an initial investment of $5m.
Growth equity firm HighCape Partners provided the capital.
The investment represents an extension of the previously announced $9m fundraising round, which closed in February 2014.
Led by and Chris Hutchison, President and CEO, Stephen Reeders, Chairman, Cheetah Medical develops the CHEETAH NICOM Hemodynamic Management System which offers a non-invasive means to measure key hemodynamic parameters. The system is currently available in more than 60 countries, including the United States.